RedHill Biopharma reported $-1.08M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Cara Therapeutics USD 14.5M 6.44M Mar/2026
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 88.73M 6.62M Jun/2026
Cronos Group USD 447.88M 620.79M Sep/2026
RedHill Biopharma USD -1.08M 5.35M Jun/2026